Conservative management of nivolumab-induced pericardial effusion: a case report and review of literature

Abstract Background Nivolumab is an immune checkpoint inhibitor targeting programmed death-1 protein and has been approved for the treatment of multiple advanced malignancies. Adverse effects of immune checkpoint inhibitors are distinct from conventional cytotoxic chemotherapy and can be life-threat...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Shagufta Shaheen, Hamid Mirshahidi, Gayathri Nagaraj, Chung-Tsen Hsueh
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2018-05-01
Schriftenreihe:Experimental Hematology & Oncology
Schlagworte:
Non-small cell lung cancer
Immune checkpoint inhibitor
Nivolumab
Pericardial effusion
Corticosteroids
Online Zugang:http://link.springer.com/article/10.1186/s40164-018-0104-y
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge